NPS discovers and develops small molecules and recombinant proteins as drugs, primarily for the treatment of metabolic, bone and mineral, and central nervous system disorders. The company has drug candidates in various stages of clinical development. Additional information is available on the company's website, http://www.npsp.com.

Contact Information

Morris Corporate Center 1 4th Floor Building B
300 Interpace Parkway
Parsippany, NJ07054

tel: 973-394-8600
fax: 973-316-6463


Investor Relations



Exchange: NASDAQ
Industry: Biotechnology
Market Cap: $203.6M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.